Latest Articles

Publication Date
The strategic role of lipidomics in biomarker identification and diagnosis of gynecological diseases.

Lipidomics, an emerging field in medical research, has deepened our understanding of lipid metabolism, signal transduction pathways, and intercellular communication through qualitative and quantitative analyses of patient lipid profiles. It …

Published: Sept. 17, 2025, midnight
Cervical Cancer Survivors at High Risk of Developing Anal Cancer - Inside Precision Medicine

Cervical Cancer Survivors at High Risk of Developing Anal Cancer Inside Precision Medicine

Published: Sept. 12, 2025, 7:50 p.m.
WVU Cancer Institute to host Gynecologic Cancer Awareness Walk - WVU Medicine

WVU Cancer Institute to host Gynecologic Cancer Awareness Walk WVU Medicine

Published: Sept. 12, 2025, 3:55 p.m.
Clinical efficacy and safety of Chinese patent medicines combined with hormonal therapy for endometriosis after laparoscopic surgery: A Bayesian network meta-analysis.

Chinese patent medicines (CPMs), standardized herbal formulations widely used in clinical practice, combined with hormones have shown favorable therapeutic effects in the adjuvant treatment of endometriosis (EMS) after laparoscopic surgery. …

Published: Sept. 6, 2025, midnight
Dynamics of Conventional Metabolic Indices in Relation to Endometriosis Severity: A Retrospective Analysis.

This study aims to investigate the association between the dynamics of routine metabolic markers and endometriosis severity.

Published: Sept. 4, 2025, midnight
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases - Yale School of Medicine

Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases Yale School of Medicine

Published: Sept. 2, 2025, 12:57 p.m.
Media Release: Backing women in medicine - Australian Medical Association

Media Release: Backing women in medicine Australian Medical Association

Published: Sept. 2, 2025, 1:05 a.m.
900+ PBS medicines will be capped at $25 from next year - The Daily Aus

900+ PBS medicines will be capped at $25 from next year The Daily Aus

Published: Sept. 2, 2025, 12:06 a.m.
Health 900+ PBS medicines will be capped at $25 from next year - The Daily Aus

Health 900+ PBS medicines will be capped at $25 from next year The Daily Aus

Published: Sept. 2, 2025, 12:06 a.m.
Triptorelin associated adverse events evaluated using FAERS pharmacovigilance data.

Triptorelin, a gonadotropin-releasing hormone(GnRH) agonist, is approved by the US Food and Drug Administration(FDA) for treating advanced prostate cancer, endometriosis, and central precocious puberty(CPP) in children aged ≥ 2 years. …

Published: Sept. 1, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!